Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology. 1999 Dec; 117(6):1278-87.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.